![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LYRM2 |
Gene summary for LYRM2 |
![]() |
Gene information | Species | Human | Gene symbol | LYRM2 | Gene ID | 57226 |
Gene name | LYR motif containing 2 | |
Gene Alias | DJ122O8.2 | |
Cytomap | 6q15 | |
Gene Type | protein-coding | GO ID | GO:0003674 | UniProtAcc | Q9NU23 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57226 | LYRM2 | S016 | Human | Liver | HCC | 1.29e-36 | 1.22e+00 | 0.2243 |
57226 | LYRM2 | S027 | Human | Liver | HCC | 5.54e-09 | 9.80e-01 | 0.2446 |
57226 | LYRM2 | S028 | Human | Liver | HCC | 3.57e-25 | 1.24e+00 | 0.2503 |
57226 | LYRM2 | S029 | Human | Liver | HCC | 2.51e-20 | 1.16e+00 | 0.2581 |
57226 | LYRM2 | C04 | Human | Oral cavity | OSCC | 1.56e-11 | 7.93e-01 | 0.2633 |
57226 | LYRM2 | C21 | Human | Oral cavity | OSCC | 1.60e-26 | 9.44e-01 | 0.2678 |
57226 | LYRM2 | C30 | Human | Oral cavity | OSCC | 3.85e-29 | 1.28e+00 | 0.3055 |
57226 | LYRM2 | C38 | Human | Oral cavity | OSCC | 5.91e-08 | 1.16e+00 | 0.172 |
57226 | LYRM2 | C43 | Human | Oral cavity | OSCC | 1.30e-05 | 2.69e-01 | 0.1704 |
57226 | LYRM2 | C46 | Human | Oral cavity | OSCC | 2.60e-10 | 4.61e-01 | 0.1673 |
57226 | LYRM2 | C51 | Human | Oral cavity | OSCC | 2.94e-03 | 4.66e-01 | 0.2674 |
57226 | LYRM2 | C57 | Human | Oral cavity | OSCC | 1.34e-03 | 3.89e-01 | 0.1679 |
57226 | LYRM2 | C08 | Human | Oral cavity | OSCC | 2.88e-18 | 5.01e-01 | 0.1919 |
57226 | LYRM2 | C09 | Human | Oral cavity | OSCC | 1.36e-03 | 3.01e-01 | 0.1431 |
57226 | LYRM2 | LN46 | Human | Oral cavity | OSCC | 9.01e-04 | 3.94e-01 | 0.1666 |
57226 | LYRM2 | SYSMH1 | Human | Oral cavity | OSCC | 2.04e-14 | 5.21e-01 | 0.1127 |
57226 | LYRM2 | SYSMH2 | Human | Oral cavity | OSCC | 6.53e-28 | 9.54e-01 | 0.2326 |
57226 | LYRM2 | SYSMH3 | Human | Oral cavity | OSCC | 8.84e-30 | 1.04e+00 | 0.2442 |
57226 | LYRM2 | SYSMH4 | Human | Oral cavity | OSCC | 2.96e-10 | 1.47e-01 | 0.1226 |
57226 | LYRM2 | SYSMH5 | Human | Oral cavity | OSCC | 1.61e-10 | 4.94e-01 | 0.0647 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
LYRM2 | insertion | Frame_Shift_Ins | novel | c.244_245insA | p.Thr82AsnfsTer14 | p.T82Nfs*14 | Q9NU23 | protein_coding | TCGA-AA-3695-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | ||
LYRM2 | SNV | Missense_Mutation | novel | c.212A>G | p.Gln71Arg | p.Q71R | Q9NU23 | protein_coding | tolerated(0.29) | probably_damaging(0.982) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
LYRM2 | SNV | Missense_Mutation | rs534210657 | c.169N>G | p.Lys57Glu | p.K57E | Q9NU23 | protein_coding | deleterious(0.03) | probably_damaging(0.994) | TCGA-95-7039-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
LYRM2 | SNV | Missense_Mutation | novel | c.186G>T | p.Glu62Asp | p.E62D | Q9NU23 | protein_coding | deleterious(0.01) | possibly_damaging(0.748) | TCGA-37-3789-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |